找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Allergy and Asthma; The Basics to Best P Massoud Mahmoudi (Editor-in-Chief) Living reference work 20200th edition allergic diseases.allerg

[复制链接]
楼主: sesamoiditis
发表于 2025-3-28 17:39:26 | 显示全部楼层
Anaphylaxis and Systemic Allergic Reactions,hylaxis is wheezing due to acute bronchospasm. Wheezing tends to occur particularly in patients with a history of asthma. Many of the symptoms of anaphylaxis are due to the effects of histamine, platelet-activating factor (PAF), and proteases on the cardiovascular, respiratory, and cutaneous systems
发表于 2025-3-28 21:32:46 | 显示全部楼层
Aspirin or Nonsteroidal Drug-Exacerbated Respiratory Disease (AERD or NERD),gnosis of N-ERD is based on a medical history suggestive of the typical clinical manifestations, and in some patients, confirmation by an oral provocation test with aspirin can be performed when necessary. Treatment of N-ERD includes patient education for careful avoidance of COX-1 inhibitors, the u
发表于 2025-3-29 00:19:46 | 显示全部楼层
Asthma in Athletes,of the presence or severity of EIB. It is important to treat EIB in a similar manner as treating asthma. Optimal treatment should not just decrease daily symptoms of asthma, but significantly attenuate or even abolish EIB. To achieve this, the health-care provider must understand the prevalence, pat
发表于 2025-3-29 04:18:49 | 显示全部楼层
发表于 2025-3-29 09:30:45 | 显示全部楼层
Bronchodilator Therapy for Asthma,ort-acting beta-agonists (SABAs) are the most effective medications available in relieving bronchospasm and preventing exercise-induced bronchospasm. LABAs, when used in fixed combination with inhaled GCs, are very effective in improving asthma control and are the preferred controller agents for ast
发表于 2025-3-29 15:28:38 | 显示全部楼层
发表于 2025-3-29 18:07:08 | 显示全部楼层
Childhood Asthma,the absence of respiratory tract infections. In all age groups, current asthma management guidelines focus on a stepwise approach to symptom and risk control while addressing comorbidities and other modifiable risk factors such as inhaler technique, treatment adherence, and environmental exposures.
发表于 2025-3-29 22:29:13 | 显示全部楼层
发表于 2025-3-30 02:26:13 | 显示全部楼层
发表于 2025-3-30 07:26:57 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-2 00:26
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表